Celcuity (CELC) Net Cash Flow Growth (1y) (2017 - 2025)
Celcuity (CELC) Net Cash Flow Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-14,223.53% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
822.63% |
| Date | Value |
|---|
| Dec 31, 2025 |
822.63% |
| Sep 30, 2025 |
256.24% |
| Jun 30, 2025 |
4,051.85% |
| Mar 31, 2025 |
-1,193.66% |
| Dec 31, 2024 |
102.17% |
| Sep 30, 2024 |
-175.61% |
| Jun 30, 2024 |
46.02% |
| Mar 31, 2024 |
-93.91% |
| Dec 31, 2023 |
114.90% |
| Sep 30, 2023 |
31.27% |
| Jun 30, 2023 |
87.70% |
| Mar 31, 2023 |
251.36% |
| Dec 31, 2022 |
-441.28% |
| Sep 30, 2022 |
-119.35% |
| Jun 30, 2022 |
-269.88% |
| Mar 31, 2022 |
-125.71% |
| Dec 31, 2021 |
-195.39% |
| Sep 30, 2021 |
2,909.88% |
| Jun 30, 2021 |
570.69% |
| Mar 31, 2021 |
1,338.88% |
